Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,200
Closed -$234K 41
2018
Q4
$234K Hold
1,200
0.06% 27
2018
Q3
$249K Hold
1,200
0.04% 38
2018
Q2
$222K Hold
1,200
0.04% 36
2018
Q1
$205K Buy
+1,200
New +$220K 0.04% 40
2016
Q1
Sell
-109,050
Closed -$17.7M 34
2015
Q4
$17.7M Buy
109,050
+5,800
+6% +$912K 4.51% 10
2015
Q3
$14.3M Sell
103,250
-3,102
-3% -$489K 3.42% 17
2015
Q2
$16.3M Buy
106,352
+2
+0% +$320 3.69% 10
2015
Q1
$17M Buy
106,350
+22,250
+26% +$3.5M 3.69% 9
2014
Q4
$13.4M Hold
84,100
2.59% 24
2014
Q3
$11.8M Hold
84,100
2.44% 25
2014
Q2
$9.96M Hold
84,100
2.15% 24
2014
Q1
$10.4M Buy
+84,100
New +$10.2M 2.24% 24

Other funds holding AMGN

Randolph Company's AMGN Position: Q1 2019 in Review

Randolph Company sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,200 shares — an estimated $234K sold.

Randolph Company first reported a position in AMGN in Q1 2014 and held it in 12 quarters. The position peaked at $17.7M in Q4 2015. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Randolph Company reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Randolph Company sold 1,200 Amgen shares in Q1 2019, an estimated $234K.
  • Randolph Company first reported a position in Amgen in Q1 2014 and held it in 12 quarters.
  • Randolph Company's Amgen position peaked at $17.7M in Q4 2015.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Randolph Company's 13F filing for Q1 2019, filed 11 Apr 2019.